Results 341 to 350 of about 3,479,441 (357)

Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke

Annals of Neurology, 1992
G. Zoppo, K. Poeck, M. Pessin, S. Wolpert, A. Furlan, A. Ferbert, M. Alberts, J. Zivin, L. Wechsler, O. Busse, R. Greenlee, L. Brass, J. Mohr, E. Feldmann, W. Hacke, C. Kase, J. Biller, D. Gress, S. Otis   +18 more
semanticscholar   +1 more source

STATs in cancer inflammation and immunity: a leading role for STAT3

Nature Reviews Cancer, 2009
Hua Yu
exaly  

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling

Nature Medicine, 2001
Olivier Nicole, Fabian Docagne, Carine Ali   +2 more
exaly  

STATs: transcriptional control and biological impact

Nature Reviews Molecular Cell Biology, 2002
David E Levy
exaly  

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.

New England Journal of Medicine, 1987
E. Topol, R. Califf, B. George, D. Kereiakes, C. Abbottsmith, R. Candela, K. Lee, B. Pitt, R. Stack, W. O’Neill   +9 more
semanticscholar   +1 more source

Roles of the RANKL–RANK axis in antitumour immunity — implications for therapy

Nature Reviews Clinical Oncology, 2018
Mark J Smyth, William C Dougall, Michele W L Teng   +2 more
exaly  

Interaction of Plasminogen Activators and Inhibitors with Plasminogen and Fibrin

Seminars in Thrombosis and Hemostasis, 1982
H R, Lijnen, D, Collen
openaire   +2 more sources

Revisiting STAT3 signalling in cancer: new and unexpected biological functions

Nature Reviews Cancer, 2014
Hua Yu
exaly  

Plasminogen-activator inhibitor type 1 and coronary artery disease.

New England Journal of Medicine, 2000
H. Kohler, P. Grant
semanticscholar   +1 more source

Regulation of type I interferon responses

Nature Reviews Immunology, 2013
Lionel B Ivashkiv, Laura Donlin
exaly